Unknown

Dataset Information

0

Structure of the AML1-ETO eTAFH domain-HEB peptide complex and its contribution to AML1-ETO activity.


ABSTRACT: AML1-ETO is the chimeric protein product of the t(8;21) in acute myeloid leukemia. The ETO portion of the fusion protein includes the eTAFH domain, which is homologous to several TATA binding protein-associated factors (TAFs) and interacts with E proteins (E2A and HEB). It has been proposed that AML1-ETO-mediated silencing of E protein function might be important for t(8;21) leukemogenesis. Here, we determined the solution structure of a complex between the AML1-ETO eTAFH domain and an interacting peptide from HEB. On the basis of the structure, key residues in AML1-ETO for HEB association were mutated. These mutations do not impair the ability of AML1-ETO to enhance the clonogenic capacity of primary mouse bone marrow cells and do not eliminate its ability to repress proliferation or granulocyte differentiation. Therefore, the eTAFH-E protein interaction appears to contribute relatively little to the activity of AML1-ETO.

SUBMITTER: Park S 

PROVIDER: S-EPMC2668852 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

2008-01-01 | S-EPMC2577924 | BioStudies
2016-01-01 | S-EPMC5336278 | BioStudies
2014-01-01 | S-EPMC3874172 | BioStudies
2010-01-01 | S-EPMC2945414 | BioStudies
2008-11-28 | GSE10578 | GEO
2013-06-20 | E-GEOD-43834 | ArrayExpress
2019-01-01 | S-EPMC6338862 | BioStudies
1000-01-01 | S-EPMC2630273 | BioStudies
2008-01-01 | S-EPMC2579385 | BioStudies
2010-01-01 | S-EPMC2883733 | BioStudies